controversies that may lead to barriers in screening, more research is needed to identify a biomarker with increased specificity and sensitivity to warrant further diagnostic testing. [8] [9] [10] The PHI is a formula based on levels of total and free PSA, and a PSA prohormone called -2[pro]PSA, which is produced more in prostate tumors. The increased specificity of -2proPSA has been shown to increase the accuracy of PHI over PSA for identifying men with nonindolent PCa and can reduce the overdiagnosis of indolent nonlethal PCa. The studies that show that PHI may be more specific than PSA for lethal PCa in studies conducted in men of European ancestry. [8] [9] [10] Thus, PHI has the potential to provide an innovative, less controversial screening biomarker than PSA but needs to be validated in AAM similar to ongoing validation studies among non-Hispanic White men. [9] [10] [11] AAM have traditionally been underrepresented in PCa research 11 and validation of the PHI as an effective PCa screening biomarker has not been conducted with AAM. 10 Validation of an innovative PCa screening biomarker in AAM has the potential to address existing barriers in screening, thereby mitigating existing health disparities. Additionally, psychosocial factors continue to exist among AAM related to controversies associated with PCa screening using PSA. The lack of clear screening guidelines for primary care physicians for AAM, false positives of PSA, and the stress of biopsies further perpetuate fear and medical mistrust for AAM, thereby further deepening the disparities in both PCa screening and research participation among AAM. [12] [13] [14] Given the potential diagnostic benefits of PHI as a PCa screening biomarker, there is a need for intentional outreach to AAM for research engagement and an urgency to validate PHI among AAM. We have a cohort of AAM undergoing prostate biopsy at three Chicago sites. This protocol aims to add 125 healthy AAM with normal PSA to serve as controls so that we can do a stage I validation of the PHI to assess its distribution in controls, men with negative biopsies, and men with high-grade PCa.
Theory and prior literature have described the benefits of a diverse study team, including racial/ethnic diversity among the PIs, 15 Our conceptual framework illustrates that using community-based participatory research approaches and social networks across different stakeholder positions may optimize the effectiveness of partnerships between community-based organizations and academic partners. Below, we describe our 1) conceptual framework, 2) aims and study design using this framework for PHI validation in AAM, and 3) emerging outcomes and lessons learned in engaging CSs. Health. 24 Additionally, the UICC is one of only a few cancer centers directly affiliated with a Federally Qualified Health
METHODS

Conceptual Framework
Center that further supports its ability to provide timely and comprehensive navigation to AAM. This criterion is based on data published by Bryc et al. 37 
NEIU. NEIU is a federally designated
Aim 1: Multiple PIs and CSs
The eight CSs represent PCa survivors (n = 3), faith-based leaders (n = 2), fraternity order member (n = 1), civic leader (n = 1), barber (n = 1), and a community social worker (n = 1).
CSs and multiple PIs endorsed their relationships as long term (5-40 years), very strong, and forged through multiple initiatives for AA health (e.g., provision of barber services, research). Table 1 This event was part of a larger PCa screening event that was 
LIMITATIONS
One critique of our approach is that the men we recruited are not from a population-based sample, which may limit the generalizability of the data. We attempted to balance our recruitment to reflect the city at large so that there was a range of education level and socioeconomic status. In fact, our data mirrors 2017 Chicago data with about 25% of men over 40 being age 65 or older in the city and our sample.
In our sample, 28.2% of AAM are married versus 25.0% of AAM in Chicago; the median income was $30,000 versus $35,296 for AAM in Chicago, and the college educational attainment rate was 32.9% in our sample versus 37.5% for AAM in Chicago. Our sample size is small, but given this is a phase I validation we have greater than 80% power to detect differences in the distributions of both PHI and PSA in AA healthy controls, men with negative biopsies, low-grade PCa and high-grade PCa.
CONCLUSIONS
The early lessons learned in the CSs PHI CHEC pilot demonstrate that engaging AAM in research can be achieved through leveraging and maintaining trusting partnerships.
Although early challenges existed related to scheduling a substantial group of solid stakeholders, this holistic, community-centric approach embodies a "for us by us" mantra of research that resonates with both the CSs and community 
